Cargando…

A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial

Backgrounds: A plug-and-play standardized algorithm to identify the ischemic risk in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) could play a valuable step to help a wide spectrum of clinic workers. This study intended to investigate the ability to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Miaohan, Li, Yi, Na, Kun, Qi, Zizhao, Ma, Sicong, Zhou, He, Xu, Xiaoming, Li, Jing, Xu, Kai, Wang, Xiaozeng, Han, Yaling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793781/
https://www.ncbi.nlm.nih.gov/pubmed/35096990
http://dx.doi.org/10.3389/fcvm.2021.756379
_version_ 1784640675047800832
author Qiu, Miaohan
Li, Yi
Na, Kun
Qi, Zizhao
Ma, Sicong
Zhou, He
Xu, Xiaoming
Li, Jing
Xu, Kai
Wang, Xiaozeng
Han, Yaling
author_facet Qiu, Miaohan
Li, Yi
Na, Kun
Qi, Zizhao
Ma, Sicong
Zhou, He
Xu, Xiaoming
Li, Jing
Xu, Kai
Wang, Xiaozeng
Han, Yaling
author_sort Qiu, Miaohan
collection PubMed
description Backgrounds: A plug-and-play standardized algorithm to identify the ischemic risk in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) could play a valuable step to help a wide spectrum of clinic workers. This study intended to investigate the ability to use the accumulation of multiple clinical routine risk scores to predict long-term ischemic events in patients with CAD undergoing PCI. Methods: This was a secondary analysis of the I-LOVE-IT 2 (Evaluate Safety and Effectiveness of the Tivoli drug-eluting stent (DES) and the Firebird DES for Treatment of Coronary Revascularization) trial, which was a prospective, multicenter, and randomized study. The Global Registry for Acute Coronary Events (GRACE), baseline Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX), residual SYNTAX, and age, creatinine, and ejection fraction (ACEF) score were calculated in all patients. Risk stratification was based on the number of these four scores that met the established thresholds for the ischemic risk. The primary end point was ischemic events at 48 months, defined as the composite of cardiac death, nonfatal myocardial infarction, stroke, or definite/probable stent thrombosis (ST). Results: The 48-month ischemic events had a significant trend for higher event rates (from 6.61 to 16.93%) with an incremental number of risk scores presenting the higher ischemic risk from 0 to ≥3 (p trend < 0.001). In addition, the categories were associated with increased risk for all components of ischemic events, including cardiac death (from 1.36 to 3.15%), myocardial infarction (MI) (from 3.31 to 9.84%), stroke (3.31 to 6.10%), definite/probable ST (from 0.58 to 1.97%), and all-cause mortality (from 2.14 to 6.30%) (all p trend < 0.05). The net reclassification index after combined with four risk scores was 12.5% (5.3–20.0%), 9.4% (2.0–16.8%), 12.1% (4.5–19.7%), and 10.7% (3.3–18.1%), which offered statistically significant improvement in the performance, compared with SYNTAX, residual SYNTAX, ACEF, and GRACE score, respectively. Conclusion: The novel multiple risk score model was significantly associated with the risk of long-term ischemic events in these patients with an increment of scores. A meaningful improvement to predict adverse outcomes when multiple risk scores were applied to risk stratification.
format Online
Article
Text
id pubmed-8793781
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87937812022-01-28 A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial Qiu, Miaohan Li, Yi Na, Kun Qi, Zizhao Ma, Sicong Zhou, He Xu, Xiaoming Li, Jing Xu, Kai Wang, Xiaozeng Han, Yaling Front Cardiovasc Med Cardiovascular Medicine Backgrounds: A plug-and-play standardized algorithm to identify the ischemic risk in patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) could play a valuable step to help a wide spectrum of clinic workers. This study intended to investigate the ability to use the accumulation of multiple clinical routine risk scores to predict long-term ischemic events in patients with CAD undergoing PCI. Methods: This was a secondary analysis of the I-LOVE-IT 2 (Evaluate Safety and Effectiveness of the Tivoli drug-eluting stent (DES) and the Firebird DES for Treatment of Coronary Revascularization) trial, which was a prospective, multicenter, and randomized study. The Global Registry for Acute Coronary Events (GRACE), baseline Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX), residual SYNTAX, and age, creatinine, and ejection fraction (ACEF) score were calculated in all patients. Risk stratification was based on the number of these four scores that met the established thresholds for the ischemic risk. The primary end point was ischemic events at 48 months, defined as the composite of cardiac death, nonfatal myocardial infarction, stroke, or definite/probable stent thrombosis (ST). Results: The 48-month ischemic events had a significant trend for higher event rates (from 6.61 to 16.93%) with an incremental number of risk scores presenting the higher ischemic risk from 0 to ≥3 (p trend < 0.001). In addition, the categories were associated with increased risk for all components of ischemic events, including cardiac death (from 1.36 to 3.15%), myocardial infarction (MI) (from 3.31 to 9.84%), stroke (3.31 to 6.10%), definite/probable ST (from 0.58 to 1.97%), and all-cause mortality (from 2.14 to 6.30%) (all p trend < 0.05). The net reclassification index after combined with four risk scores was 12.5% (5.3–20.0%), 9.4% (2.0–16.8%), 12.1% (4.5–19.7%), and 10.7% (3.3–18.1%), which offered statistically significant improvement in the performance, compared with SYNTAX, residual SYNTAX, ACEF, and GRACE score, respectively. Conclusion: The novel multiple risk score model was significantly associated with the risk of long-term ischemic events in these patients with an increment of scores. A meaningful improvement to predict adverse outcomes when multiple risk scores were applied to risk stratification. Frontiers Media S.A. 2022-01-13 /pmc/articles/PMC8793781/ /pubmed/35096990 http://dx.doi.org/10.3389/fcvm.2021.756379 Text en Copyright © 2022 Qiu, Li, Na, Qi, Ma, Zhou, Xu, Li, Xu, Wang and Han. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Qiu, Miaohan
Li, Yi
Na, Kun
Qi, Zizhao
Ma, Sicong
Zhou, He
Xu, Xiaoming
Li, Jing
Xu, Kai
Wang, Xiaozeng
Han, Yaling
A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title_full A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title_fullStr A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title_full_unstemmed A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title_short A Novel Multiple Risk Score Model for Prediction of Long-Term Ischemic Risk in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: Insights From the I-LOVE-IT 2 Trial
title_sort novel multiple risk score model for prediction of long-term ischemic risk in patients with coronary artery disease undergoing percutaneous coronary intervention: insights from the i-love-it 2 trial
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793781/
https://www.ncbi.nlm.nih.gov/pubmed/35096990
http://dx.doi.org/10.3389/fcvm.2021.756379
work_keys_str_mv AT qiumiaohan anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT liyi anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT nakun anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT qizizhao anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT masicong anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT zhouhe anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT xuxiaoming anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT lijing anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT xukai anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT wangxiaozeng anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT hanyaling anovelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT qiumiaohan novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT liyi novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT nakun novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT qizizhao novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT masicong novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT zhouhe novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT xuxiaoming novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT lijing novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT xukai novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT wangxiaozeng novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial
AT hanyaling novelmultipleriskscoremodelforpredictionoflongtermischemicriskinpatientswithcoronaryarterydiseaseundergoingpercutaneouscoronaryinterventioninsightsfromtheiloveit2trial